Retinoblastoma is the most frequent intraocular malignancy in children, originating from a
maturing cone precursor in the developing retina. Little is known on the molecular basis …

Retinoblastoma is caused by mutational inactivation of both alleles of the RB1 gene, which
maps to chromosome 13q14 and encodes retinoblastoma protein that acts as a tumor …

Over the last two decades, nanoparticulate delivery systems have revolutionized cancer
treatment by achieving target-specific delivery, enhanced bioavailability, and improved …

Simple Summary Effective management of retinoblastoma (RB), a common childhood eye
cancer, requires accurate diagnosis and monitoring during therapy. In this study, the liquid …

Long non-coding RNA (lncRNA) X–inactive specific transcript (XIST) is oncogenic in multiple
cancers. Herein, the present study is aimed at delving into how XIST functions in …

Simple Summary To date, there is no treatment for metastatic uveal melanoma. Identifying its
metastatic spread is essential. Liquid biopsy can identify patients at risk of metastatic spread …

Retinoblastoma, the primary ocular malignancy in pediatric patients, poses a substantial
threat to mortality without prompt and effective management. The prognosis for survival and …

Current cure rates for retinoblastoma (RB) are very high in developed countries.
Nonetheless, in less privileged places worldwide, delayed diagnosis and refusal to adhere …

Simple Summary Retinoblastoma is the most common ocular tumor among children.
Typically, individuals with retinoblastoma are regularly monitored with diagnostic techniques …

Long non-coding RNAs (lncRNAs) are key regulators of cancer. However, the role of long
intergenic non-protein coding RNA 115 (LINC00115) in the regulation of retinoblastoma …